Company: AIP
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001628280-25-048977
Chunk: 260

Company: Arteris, Inc.
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 8
Chunk 260
---
 and 2024, respectively.As of September 30, 2025, there was $1.9 million of unamortized stock-based compensation cost related to unvested stock options, which is expected to be recognized over a weighted-average period of 2.9 years.Restricted Stock Units and Awards The following table summarizes the restricted stock unit activities under the 2016 Plan, the 2021 Plan and the 2022 Inducement Plan:Restricted Stock UnitsNumber of SharesWeighted-Average Grant Date Fair ValueUnvested—December 31, 20245,225,948 $7.00 Granted1,811,012 $8.20 Vested(2,111,603)$7.04 Canceled (164,855)$7.73 Unvested—September 30, 20254,760,502 $7.41 The total grant-date fair value of restricted stock units vested was $14.8 million and $13.2 million during the nine months ended September 30, 2025 and 2024, respectively.As of September 30, 2025, there was $31.6 million of unamortized stock-based compensation cost related to unvested restricted stock units, which is expected to be recognized over a weighted-average period of 2.6 years.2021 Employee Stock Purchase PlanThe Company adopted the 2021 Employee Stock Purchase Plan (the 2021 ESPP) effective on October 26, 2021. The 2021 ESPP enables eligible employees of the Company to purchase shares of common stock at a discount to fair market value. The 2021 ESPP provides for six-month offering periods beginning May 22 and November 22 of each year, and each offering period consists of a six-month purchase period. The first offering period began on May 22, 2024 and ended on November 21, 2024. During the nine months ended September 30, 2025, 88,668 shares of common stock were purchased under the 2021 ESPP. As of September 30, 2025, 1,882,728 shares of common stock were available for future issuance under the 2021 ESPP.

18

On each purchase date, eligible employees are entitled to purchase the shares at a price per share equal to 85% of the lesser of (1) the fair market value of our common stock on the offering date or (2)